TrialThe oncologist2025

A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies.

Jibran Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.